298 related articles for article (PubMed ID: 19160325)
1. Pre and peri-operative erythropoietin for reducing allogeneic blood transfusions in colorectal cancer surgery.
Devon KM; McLeod RS
Cochrane Database Syst Rev; 2009 Jan; (1):CD007148. PubMed ID: 19160325
[TBL] [Abstract][Full Text] [Related]
2. Iron therapy for pre-operative anaemia.
Ng O; Keeler BD; Mishra A; Simpson A; Neal K; Brookes MJ; Acheson AG
Cochrane Database Syst Rev; 2015 Dec; (12):CD011588. PubMed ID: 26694949
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.
Kaufner L; von Heymann C; Henkelmann A; Pace NL; Weibel S; Kranke P; Meerpohl JJ; Gill R
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012451. PubMed ID: 32790892
[TBL] [Abstract][Full Text] [Related]
4. Fibrin sealant use for minimising peri-operative allogeneic blood transfusion.
Carless PA; Henry DA; Anthony DM
Cochrane Database Syst Rev; 2003; 2003(2):CD004171. PubMed ID: 12804501
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin for patients with malignant disease.
Bohlius J; Langensiepen S; Schwarzer G; Seidenfeld J; Piper M; Bennet C; Engert A
Cochrane Database Syst Rev; 2004; (3):CD003407. PubMed ID: 15266483
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin or darbepoetin for patients with cancer.
Bohlius J; Wilson J; Seidenfeld J; Piper M; Schwarzer G; Sandercock J; Trelle S; Weingart O; Bayliss S; Brunskill S; Djulbegovic B; Benett CL; Langensiepen S; Hyde C; Engert E
Cochrane Database Syst Rev; 2006 Jul; (3):CD003407. PubMed ID: 16856007
[TBL] [Abstract][Full Text] [Related]
7. [The role of human recombinant erythropoietin in oncologic surgery].
Mercuriali F
Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.
Bohlius J; Langensiepen S; Schwarzer G; Seidenfeld J; Piper M; Bennett C; Engert A
J Natl Cancer Inst; 2005 Apr; 97(7):489-98. PubMed ID: 15812074
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.
Zarychanski R; Turgeon AF; McIntyre L; Fergusson DA
CMAJ; 2007 Sep; 177(7):725-34. PubMed ID: 17823140
[TBL] [Abstract][Full Text] [Related]
10. Platelet-rich-plasmapheresis for minimising peri-operative allogeneic blood transfusion.
Carless PA; Rubens FD; Anthony DM; O'Connell D; Henry DA
Cochrane Database Syst Rev; 2011 Mar; (3):CD004172. PubMed ID: 21412885
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
Laupacis A; Fergusson D
Transfus Med; 1998 Dec; 8(4):309-17. PubMed ID: 9881425
[TBL] [Abstract][Full Text] [Related]
13. The impact of perioperative iron on the use of red blood cell transfusions in gastrointestinal surgery: a systematic review and meta-analysis.
Hallet J; Hanif A; Callum J; Pronina I; Wallace D; Yohanathan L; McLeod R; Coburn N
Transfus Med Rev; 2014 Oct; 28(4):205-11. PubMed ID: 24997001
[TBL] [Abstract][Full Text] [Related]
14. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Khan I; Rabindranath K; Vale L; Wallace S; Macleod A
Cochrane Database Syst Rev; 2005 Jul; (3):CD003266. PubMed ID: 16034896
[TBL] [Abstract][Full Text] [Related]
16. Anemia in the critically ill.
Shander A
Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
[TBL] [Abstract][Full Text] [Related]
17. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
[TBL] [Abstract][Full Text] [Related]
18. Impact of Preoperative Erythropoietin on Allogeneic Blood Transfusions in Surgical Patients: Results From a Systematic Review and Meta-analysis.
Cho BC; Serini J; Zorrilla-Vaca A; Scott MJ; Gehrie EA; Frank SM; Grant MC
Anesth Analg; 2019 May; 128(5):981-992. PubMed ID: 30649068
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period: reduced need for blood transfusions in patients undergoing colorectal surgery--prospective double-blind placebo-controlled study.
Qvist N; Boesby S; Wolff B; Hansen CP
World J Surg; 1999 Jan; 23(1):30-5. PubMed ID: 9841760
[TBL] [Abstract][Full Text] [Related]
20. Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.
Ross SD; Allen IE; Henry DH; Seaman C; Sercus B; Goodnough LT
Clin Ther; 2006 Jun; 28(6):801-31. PubMed ID: 16860166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
